# Globus Medical to acquire Nevro Corp.

Globus Medical has entered into a definitive agreement to acquire Nevro Corp., a medical technology company focused on chronic pain therapies. The transaction is expected to close in Q2 2025, creating a combined company with $3 billion in annual sales.

- Type: Acquisition
- Announced: 2025-02-06
- Where: United States
- Value: $250.0M
- Status: announced
- Products: musculoskeletal solutions, high-frequency SCS therapy, SI joint fusion products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Globus Medical](https://endata.com/companies/26057.md) (acquirer)
- [Nevro](https://endata.com/companies/49893.md) (target)

## Sources

- [sec.gov](https://www.sec.gov/Archives/edgar/data/1444380/000119312525021775/d909040dex994.htm), 2025-02-06: "Today Nevro Corp. and Globus Medical announced that we have entered into a definitive agreement for Globus Medical to acquire Nevro."
- [morningstar.com](https://www.morningstar.com/news/globe-newswire/9354260/globus-medical-to-acquire-nevro-corp-to-expand-treatment-options-for-patients), 2025-02-06: "This transaction furthers our mission to become the preeminent musculoskeletal technology company in the world by enabling us to expand into new markets for future growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.